Trial intelligence / Profile preview

Terbinafine and Q-Switched Nd:YAG Laser for Onychomycosis

NCT07869706Not yet recruiting

Sponsor
Assiut University
Start
Oct 2026
Primary completion
Oct 2027
01

Overview

Randomised, open-label trial in onychomycosis (2 arms), sponsored by Assiut University. Primary endpoint: Change in Onychomycosis Severity Index at 3 months. Planned start Oct 2026; status: not yet recruiting.

02

Conditions

onychomycosis

Beyond the preview

Go deeper on NCT07869706.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07869706.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call